These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 15694238
1. Distinct effects of sleep deprivation on binding to norepinephrine and serotonin transporters in rat brain. Hipólide DC, Moreira KM, Barlow KB, Wilson AA, Nobrega JN, Tufik S. Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):297-303. PubMed ID: 15694238 [Abstract] [Full Text] [Related]
2. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Wang X, Baumann MH, Xu H, Rothman RB. Synapse; 2004 Sep 15; 53(4):240-8. PubMed ID: 15266556 [Abstract] [Full Text] [Related]
3. Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency. Milak MS, Ogden RT, Vinocur DN, Van Heertum RL, Cooper TB, Mann JJ, Parsey RV. Biol Psychiatry; 2005 Jan 01; 57(1):102-6. PubMed ID: 15607307 [Abstract] [Full Text] [Related]
4. Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB). Li Q, Ma L, Innis RB, Seneca N, Ichise M, Huang H, Laruelle M, Murphy DL. J Pharmacol Exp Ther; 2004 Feb 01; 308(2):481-6. PubMed ID: 14610240 [Abstract] [Full Text] [Related]
5. Substituted amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expression. Rothman RB, Jayanthi S, Cadet JL, Wang X, Dersch CM, Baumann MH. Ann N Y Acad Sci; 2004 Oct 01; 1025():151-61. PubMed ID: 15542713 [Abstract] [Full Text] [Related]
6. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression. Szapacs ME, Mathews TA, Tessarollo L, Ernest Lyons W, Mamounas LA, Andrews AM. J Neurosci Methods; 2004 Dec 30; 140(1-2):81-92. PubMed ID: 15589338 [Abstract] [Full Text] [Related]
7. Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner. Zhang S, Zhen J, Reith ME, Dutta AK. J Med Chem; 2005 Jul 28; 48(15):4962-71. PubMed ID: 16033275 [Abstract] [Full Text] [Related]
8. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects. Belej T, Manji D, Sioutis S, Barros HM, Nobrega JN. Brain Res; 1996 Oct 14; 736(1-2):287-96. PubMed ID: 8930335 [Abstract] [Full Text] [Related]
9. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP, Bilbe G, Hoyer D, Bartfai T. Mol Psychiatry; 2007 Feb 14; 12(2):167-89. PubMed ID: 17033635 [Abstract] [Full Text] [Related]
10. Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity. Chalon S, Tarkiainen J, Garreau L, Hall H, Emond P, Vercouillie J, Farde L, Dasse P, Varnas K, Besnard JC, Halldin C, Guilloteau D. J Pharmacol Exp Ther; 2003 Jan 14; 304(1):81-7. PubMed ID: 12490578 [Abstract] [Full Text] [Related]
11. Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter. Nandi A, Dersch CM, Kulshrestha M, Ananthan S, Rothman RB. Synapse; 2004 Sep 01; 53(3):176-83. PubMed ID: 15236350 [Abstract] [Full Text] [Related]
12. Iron deficiency: differential effects on monoamine transporters. Burhans MS, Dailey C, Beard Z, Wiesinger J, Murray-Kolb L, Jones BC, Beard JL. Nutr Neurosci; 2005 Feb 01; 8(1):31-8. PubMed ID: 15909765 [Abstract] [Full Text] [Related]
13. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Rothman RB, Jayanthi S, Wang X, Dersch CM, Cadet JL, Prisinzano T, Rice KC, Baumann MH. Synapse; 2003 Dec 01; 50(3):233-9. PubMed ID: 14515341 [Abstract] [Full Text] [Related]
14. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, Andrews AM. J Neurosci Methods; 2004 Dec 30; 140(1-2):169-81. PubMed ID: 15589347 [Abstract] [Full Text] [Related]
16. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents. Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M. J Med Chem; 2005 Apr 07; 48(7):2559-70. PubMed ID: 15801845 [Abstract] [Full Text] [Related]
18. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM. Neuropharmacology; 2008 Nov 07; 55(6):1006-14. PubMed ID: 18761360 [Abstract] [Full Text] [Related]
19. Heterogeneous targeting of centrifugal inputs to the glomerular layer of the main olfactory bulb. Gómez C, Briñón JG, Barbado MV, Weruaga E, Valero J, Alonso JR. J Chem Neuroanat; 2005 Jun 07; 29(4):238-54. PubMed ID: 15927786 [Abstract] [Full Text] [Related]